Literature DB >> 3809732

Porcine parvovirus: propagation in microcarrier cell culture and immunogenic evaluation in pregnant gilts.

E Rivera, C G Sjösten, R Bergman, K A Karlsson.   

Abstract

Porcine parvovirus was propagated in PK-15 cells cultured in roller bottles or on microcarrier beads. After inactivation, the virus was used as antigen in the preparation of vaccines. The immunogenic potency and safety of the vaccines were evaluated in specific pathogen free pregnant gilts and guinea pigs. Experimental challenge tests determined the efficacy of the vaccine in preventing porcine parvovirus transplacental infection. Neither viral antigens nor specific antibodies were detected in fetuses from vaccinated gilts. In contrast, fetal death and, or, mummification occurred when unvaccinated gilts were infected. Both virus and, or, antibodies were also detected in fetuses from these unvaccinated gilts. Serum conversion after vaccination was assayed by microserum neutralisation using guinea pig erythrocytes as cell indicators and by haemagglutination inhibition tests. Viral antigens in fetal tissues were detected using ELISA, the immunobeads technique, the haemagglutination test and by virus isolation.

Entities:  

Mesh:

Year:  1986        PMID: 3809732

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  3 in total

1.  A solid phase fluorescent immunoassay for the rapid detection of virus antigen or antibodies in fetuses infected with porcine parvovirus.

Authors:  E Rivera; L Sjöland; K A Karlsson
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Detection of challenge virus in fetal tissues by nested PCR as a test of the potency of a porcine parvovirus vaccine.

Authors:  S Belák; E Rivera; A Ballagi-Pordány; W Hanzhong; F Widén; T Soós
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

3.  High titre Hog Cholera virus production on Cytodex 3 microcarrier cultures.

Authors:  A Caij; A De Smet; N Dubois; F Koenen
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.